External Source Analysis
NZ Health Science Institute — Public Health Information Service healthscienceinstitute.org.nz
HSI
New Zealand Health Science Institute

Vaccines and Immunisation: A Scientific Overview

Summary

Vaccines work by training the immune system to recognise and respond to specific pathogens without causing the disease itself. This article explains the biological mechanisms of vaccine-induced immunity, reviews the major classes of vaccines in current use, describes the evidence base for vaccination programmes, and addresses common questions about vaccine safety and efficacy.

How the Immune System Responds to Infection

When the body encounters a pathogen — a virus, bacterium, or other disease-causing organism — the immune system mounts a two-stage defence. The innate immune response acts immediately, causing inflammation and deploying non-specific immune cells. Within days, the adaptive immune response activates: B cells produce antibodies specific to the pathogen, and T cells either destroy infected cells (cytotoxic T cells) or coordinate the immune response (helper T cells).[1]

Crucially, the adaptive immune system retains a memory of pathogens it has encountered. Memory B and T cells persist long after an infection resolves, enabling a faster and stronger response if the same pathogen is encountered again. This is the biological basis of immunity — and the mechanism that vaccines exploit.[2]

How Vaccines Work

Vaccines introduce the immune system to a pathogen or a component of one — without causing disease. The immune system mounts a response, produces antibodies, and creates immunological memory. If the vaccinated person later encounters the real pathogen, the immune system can respond rapidly, typically preventing severe illness or death.[3]

The key insight, first applied by Edward Jenner in 1796 using cowpox to protect against smallpox, is that immunity can be acquired through a controlled exposure that does not itself cause the disease.[4]

Types of Vaccines

Several distinct vaccine technologies are currently in use:

Vaccine Type How It Works Examples
Live-attenuated Uses a weakened form of the pathogen; produces strong, long-lasting immunity MMR (measles, mumps, rubella); chickenpox
Inactivated Uses a killed pathogen; generally requires multiple doses or boosters Influenza (injected); polio (IPV)
Subunit / protein Uses specific proteins from the pathogen's surface to trigger immune response Hepatitis B; pertussis (whooping cough) component
Toxoid Uses an inactivated toxin produced by the pathogen Tetanus; diphtheria
mRNA Delivers genetic instructions for cells to produce a harmless antigen; immune system responds to this antigen Pfizer-BioNTech and Moderna COVID-19 vaccines

Herd Immunity

When a sufficiently high proportion of a population is immune to an infectious disease — through vaccination or prior infection — the pathogen cannot spread easily, protecting even those who are not themselves immune. This is called herd immunity (or population immunity).[5]

The proportion of the population that needs to be immune for herd immunity to operate — the herd immunity threshold — varies by disease. Measles, which is highly contagious, requires approximately 95% of the population to be immune. For COVID-19, estimates have ranged more widely depending on viral variant.[6]

Herd immunity is particularly important for protecting people who cannot be vaccinated, including newborns, immunocompromised individuals, and those with certain allergies.[5]

The Evidence Base for Vaccination

The evidence supporting vaccination is among the strongest in all of medicine. The eradication of smallpox — declared in 1980 after a global vaccination campaign — is the clearest demonstration. Polio, which once paralysed tens of thousands of children annually, has been eliminated from most of the world through vaccination. The incidence of diseases including measles, diphtheria, whooping cough, and rubella has declined by more than 99% in countries with sustained vaccination programmes.[7]

In New Zealand, the Immunisation Advisory Centre reports that childhood vaccination coverage has consistently prevented thousands of hospitalisations annually. The 2019 measles outbreak in New Zealand — concentrated in communities with lower vaccination rates — illustrated the consequences of declining immunisation coverage.[8]

Vaccine Safety: How It Is Monitored

Before a vaccine is approved for use, it must pass through several phases of clinical trials involving thousands to tens of thousands of participants. These trials assess both efficacy (does it produce immunity?) and safety (what are the side effects?).[9]

Most side effects from vaccines are mild and temporary: soreness at the injection site, mild fever, fatigue. These reflect the immune system activating — they are signs that the vaccine is working. Serious adverse events are rare and are tracked through ongoing post-market surveillance systems. In New Zealand, CARM (the Centre for Adverse Reactions Monitoring) records and investigates reported adverse events following immunisation.[10]

No medical intervention is entirely without risk. The relevant question is always comparative: what is the risk of the vaccine versus the risk of the disease it prevents? For all vaccines currently recommended in New Zealand, the evidence consistently shows that the benefits substantially outweigh the risks.[9]

Common Questions

Can vaccines cause the disease they are meant to prevent?

In the case of live-attenuated vaccines, the vaccine contains a weakened pathogen that cannot cause disease in healthy people. In immunocompromised individuals, these vaccines require careful consideration. Inactivated, subunit, toxoid, and mRNA vaccines do not contain live pathogens and cannot cause the disease they target.[3]

Do vaccines contain harmful ingredients?

Vaccines contain adjuvants (substances that enhance the immune response, such as aluminium salts), preservatives, stabilisers, and residual manufacturing substances in very small quantities. These components are subject to rigorous safety testing. The quantities involved are typically far below levels associated with adverse effects.[11]

References

  1. Janeway CA, et al. Immunobiology: The Immune System in Health and Disease. 9th ed. Garland Science; 2022.
  2. Crotty S. "T follicular helper cell differentiation, function, and roles in disease." Immunity. 2019;41(4):529–542. doi:10.1016/j.immuni.2014.09.002
  3. World Health Organization. Vaccines and Immunization: What is Vaccination? WHO; 2023. Available at: who.int/news-room/questions-and-answers/item/vaccines-and-immunization-what-is-vaccination
  4. Riedel S. "Edward Jenner and the history of smallpox and vaccination." Proc (Bayl Univ Med Cent). 2005;18(1):21–25.
  5. Fine P, Eames K, Heymann DL. "'Herd immunity': a rough guide." Clin Infect Dis. 2011;52(7):911–916.
  6. Randolph HE, Barreiro LB. "Herd Immunity: Understanding COVID-19." Immunity. 2020;52(5):737–741.
  7. Centers for Disease Control and Prevention. Vaccines and Preventable Diseases: Achievements in Public Health. CDC; 2023.
  8. Immunisation Advisory Centre, University of Auckland. New Zealand Immunisation Handbook 2024. Ministry of Health; 2024.
  9. Plotkin SA, Orenstein WA, Offit PA. Vaccines. 7th ed. Elsevier; 2018.
  10. Centre for Adverse Reactions Monitoring (CARM). Annual Report 2023. University of Otago; 2024.
  11. Offit PA, Jew RK. "Addressing Parents' Concerns: Do Vaccines Contain Harmful Preservatives, Adjuvants, Additives, or Residuals?" Pediatrics. 2003;112(6):1394–1397.